Skip to main content

Sarah- Week 4

Going into this week, I was a little bit terrified.  My grad student, being away this week, had left me a list of tasks to complete and some protocols.  I really did not want to have to send a text to her saying, "Please help.  I messed up a lot!"  (spoiler alert: I didn't have to) My first job on Monday was to rinse a primary antibody off of western blots and to then put on a secondary.  I was in charge of four westerns which had different lid covers and were all slightly different from each other.  Two westerns followed one protocol and the other two followed another protocol.  When I put the westerns down, I oriented them in a certain way so that I would not accidentally switch the lids.  I then had to rinse off the secondary and expose the westerns to ECL in order for the proteins to become visible in the imager.  After successfully imaging the westerns, I used the stripping buffer in order to prepare them for the next primary, in order to repeat the process again the next day.  I very carefully walked the western blots over to the cold room to allow them to incubate overnight on the rocker.
Next, I had to fix two plates of cells and then do the first day of the cell-staining procedure.  The cells were first sitting in media which had a salmon pink color to it.  I had to first vacuum out this media and then rinse the cells with PBS and PBSt solution.  It was really important not to confuse PBS with PBSt because PBSt contains a detergent which is not in PBS.  I also had to treat the plates with Cy3 or FitC depending on the step.  I have found that a lot of research is waiting time, which felt a little longer than usual this week with a few less people in the lab than usual due to the 4th of July.
The next day, I repeated the western procedure and reimaged the blots before beginning the second day of the cell- staining procedure.  As the plates were now light sensitive, I had to keep them wrapped in tin foil.  I have gotten into the habit of leaving them in a drawer by the vacuum when they are not on a rocker in order to keep them out of the way and out of the light.  After all of the westerns and the plates were placed on the rocker in the cold room, I extracted DNA from tail samples in order to prepare them for PCR.  There were only two samples, but the controls, including no DNA, also had to be put into the PCR machine.
On Wednesday and Thursday, I was able to spend time with my cousin and parents, thanks to 4th of July.
On Friday, I was back in the lab!  I added loading dye to my PCR-ed samples before running them in a gel for an hour.  During this time, I began the western procedure once again, and continued with day 3 of the cell staining procedure.  While the cell plates were incubating, and the westerns were resting on the rocker, I imaged the gel.  The image was a little bit streakier than I would have liked, probably due to an excess of DNA being loaded, but I was overall happy with my work.
I was really proud of myself this week for being able to manage a few different things, finding all the necessary chemicals, and for going through the procedures without becoming confused by all of the steps.

Comments

  1. Sounds like you did a great job keeping it all organized!

    ReplyDelete

Post a Comment

Popular posts from this blog

Kylie Heering, Week 2 at the Goldstein Lab

We started off our week with a congratulatory acai bowl trip to celebrate Preston’s acceptance into a training grant program. Acai bowls in California top Playa Bowls (no question about it). From what I can tell, its a pretty huge honor to be recognized by this grant, but he’s really humble about it. On Monday, Preston and I decided that testing antibodies that have never been tested on prostate epithelial cells before would be a good objective for my first Western blot on my own. We needed to probe for ASCT2, a glutamine transporter, and GLS in order to determine if their corresponding antibodies are functional. Antibodies are crucial for Western blots because they bind to the protein of interest (POI), allowing for us to qualify its expression after imaging. As such, Preston wanted to make sure they worked by probing for ASCT2 and GLS on three different cell lines. Cell lines are commercially purchased human cells that have been immortalized (modified to grow indefinitely) by telome...

Alan - First Week at UCSF

Hi Everyone! After arriving in San Francisco last Sunday, I spent this past week settling into the downtown Berkeley apartment that I’ll be sharing with Rohit for the next couple of months, as well as learning my way around the Roy lab at UCSF. First day at the lab was really exciting. Here are a couple pictures of the Mission Bay campus, which was completed just a few years ago. Everything is super new and modern, and there’s still construction for other buildings going on around the campus. Most of the people who work at the Mission Bay campus are either professional researchers or doctors/nurses for the nearby hospital. The graduate students take most of their classes at the original Parnassus campus (where Maya is). I work in Byers Hall, which is connected to Genentech Hall and a short walk down the block from the shuttle stop. There are three other volunteers working for the Roy lab this summer – Kimmai, David, and Pujita, who are all undergrad college students...

Jaewon Oh - Week 7 and 8

Finally done here with my experience and I wish I had more time keep researching so that I have something a little more "finalised" to present. But I guess that's what past EXP kids meant when they said that 8 weeks of research is not enough and I'll have to work with what I've got. To solve the problem of not having enough data points, we used the online TCGA database for raw data that would be used to calculate mutation rates. Mutation rates were calculated through an R coding script that Dr. Cannataro had made. Because the mutation rates were tumor specific, we had to change the proportions that were obtained from the IARC database using data from another database called cBioPortal. Basically we had to multiply the number of times a certain variant was seen in the IARC database by the percentage of tumors that have a tp53 mutation, because our mutation rates are calculated across all tumors in specific cancers (confusing, I know). After graphing the mutatio...